The Cleveland Clinic Foundation, OH. Text provides a comprehensive overview of the clinical development of the class of glycoprotein IIb/IIIa receptor antagonists. Includes new information from trials using glycoprotein and its role in coronary vascular disease and acute coronary syndromes. Previous edition: c1999. DNLM: Cardiovascular Diseases.
